<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ARNA</title>
    <link />
    <description>Headlines for Arena Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Arena - Good Sales, Bad Sales, Long And Short</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1458991-arena-good-sales-bad-sales-long-and-short.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 24 May 2013 02:53:48 GMT</pubDate>
    </item>
    <item>
      <title>First Manhattan Still Playing Hardball With Vivus</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1458891-first-manhattan-still-playing-hardball-with-vivus.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 24 May 2013 00:06:23 GMT</pubDate>
    </item>
    <item>
      <title>Arena Is Still A Great Short</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1457831-arena-is-still-a-great-short.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 23 May 2013 15:08:01 GMT</pubDate>
    </item>
    <item>
      <title>Arena Buyout More 'Highly Probable' Than MannKind</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1457311-arena-buyout-more-highly-probable-than-mannkind.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 23 May 2013 13:20:46 GMT</pubDate>
    </item>
    <item>
      <title>Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1455641-why-doctors-can-prescribe-arena-s-belviq-for-off-label-uses-without-worrying-about-legal-liability.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 23:06:12 GMT</pubDate>
    </item>
    <item>
      <title>3 Pipeline Obesity Treatments You Should Watch</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/3-pipeline-obesity-treatments-to-watch/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Arena Pharmaceuticals - Out To Launch Or Out To Lunch?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1452341-arena-pharmaceuticals-out-to-launch-or-out-to-lunch.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 03:19:04 GMT</pubDate>
    </item>
    <item>
      <title>The Surprising Link Between ADHD and Obesity</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/the-surprising-link-between-adhd-and-obesity/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1449221-the-facebook-effect-on-arena-s-belviq-sales-and-why-it-will-ultimately-dwarf-anything-eisai-does.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 06:56:25 GMT</pubDate>
    </item>
    <item>
      <title>The 9 Most Obese Countries in the World</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/the-9-most-obese-countries-in-the-world/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 14:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Vivus Taps Into More Cash</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1445401-vivus-taps-into-more-cash.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 19 May 2013 09:41:19 GMT</pubDate>
    </item>
    <item>
      <title>25 Belt-Busting Obesity Facts</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/25-belt-busting-obesity-facts/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Arena Outlines Belviq Launch And Goals</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1442611-arena-outlines-belviq-launch-and-goals.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 17 May 2013 02:01:52 GMT</pubDate>
    </item>
    <item>
      <title>Weight Loss Isn't Just for Looking Good Anymore</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/weight-loss-isnt-just-for-looking-good-anymore/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 19:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Vivus - Mild Drama Continues</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1436491-vivus-mild-drama-continues.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 10:18:45 GMT</pubDate>
    </item>
    <item>
      <title>Vivus Starting To Gain The Advantage Over Arena</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1432481-vivus-starting-to-gain-the-advantage-over-arena.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 05:42:05 GMT</pubDate>
    </item>
    <item>
      <title>Arena, Vivus, And Off-Label Prescriptions</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1432021-arena-vivus-and-off-label-prescriptions.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 01:08:26 GMT</pubDate>
    </item>
    <item>
      <title>Deal Discussions Distract From Disappointing Obesity Drug Sales</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/11/deal-discussions-distract-from-disappointing-obesi/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 11 May 2013 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Short Interest in Vertex Rises, in Celgene Falls</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/short-ideas/13/05/3581061/short-interest-in-vertex-rises-in-celgene-falls.aspx</link>
      <author>Benzinga</author>
      <pubDate>Sat, 11 May 2013 10:45:31 GMT</pubDate>
    </item>
    <item>
      <title>Belviq's Sales Will Disappoint: Demographics Matter</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1424811-belviq-s-sales-will-disappoint-demographics-matter.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 14:31:22 GMT</pubDate>
    </item>
  </channel>
</rss>
